Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Budgeting tools can simplify your financial planning. Learn about effective resources to help you manage your budget and achieve your financial goals.
6,588 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Global X's XYLD ETF continues to deliver monthly payouts through a covered-call strategy, but a persistent drag on to...
Gary Keller argues that a data-driven view can outweigh market gloom, foreseeing 4.3 million home sales in 2026 and a...
A high-stakes move by a leading investment manager has turned heads in the tech infrastructure space. This article ex...
A sharp stock drop often triggers fear, but a sizable buy can signal belief in a company’s growth path. This article ...
A high-profile stage moment reshaped Jelly Roll's narrative, but off-camera leaks can quietly alter financial outcome...
Virginia-based City Lending Inc. is winding down operations as regulators tighten oversight and the mortgage market c...
A fresh wave of buying interest in XRP, Solana, and Shiba Inu hits the market as traders watch key resistance levels ...
Major asset managers are taking stakes in DeFi tokens, a move that marks a shift from speculation to strategic exposu...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...